Correct answer: (a) Vaccine against Malaria developed by Serum Institute of India
Explanation
- A
Vaccine against Malaria developed by Serum Institute of India
This option claims that R21/Matrix-M is a vaccine against malaria developed by the Serum Institute of India. This is the official key because the R21/Matrix-M malaria vaccine has been manufactured and produced at a massive scale by the Serum Institute of India in collaboration with the University of Oxford and Novavax.
- B
Vaccine against Malaria developed by Bharat Biotech International
This option states that the vaccine was developed by Bharat Biotech International. While Bharat Biotech is a major Indian vaccine manufacturer, it is not the developer or primary manufacturer of the R21/Matrix-M malaria vaccine.
- C
Vaccine against AIDS developed by Serum Institute of India
This option identifies the vaccine as being against AIDS and developed by the Serum Institute of India. R21/Matrix-M is specifically a malaria vaccine, not an AIDS vaccine, making this choice factually incorrect.
- D
Vaccine against AIDS developed by Bharat Biotech International
This option claims it is an AIDS vaccine developed by Bharat Biotech International. This is completely false because neither the disease target nor the developing institution matches the actual profile of R21/Matrix-M.
Summary. Official key is (a) Vaccine against Malaria developed by Serum Institute of India. The R21/Matrix-M vaccine represents a significant breakthrough in global health, endorsed by the World Health Organization for preventing malaria in children. Candidates must remember that Serum Institute of India partners with global developers for such vaccines rather than Bharat Biotech. Confusing malaria with AIDS or mixing up Indian vaccine manufacturers leads to negative marking. Thus, option (a) stands out as the only completely accurate description among the choices provided.